| Literature DB >> 36245719 |
Sasa Milivojevic1, Aleksandra Zelenovic2, Jelena Milin-Lazovic3, Ognjen Radojicic4, Darko Laketic2, Ivana Dasic1, Natasa Milic3,5, Zoran Radojicic1.
Abstract
Background: The aim of this study was to examine the correlation between the transverse rectal diameter and urodynamic findings in children with neurogenic bowel and bladder dysfunction.Entities:
Keywords: bladder dysfunction; neurogenic bowel; spina bifida; transverse rectal diameter; urodynamic findings
Year: 2022 PMID: 36245719 PMCID: PMC9557052 DOI: 10.3389/fped.2022.957123
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
Baseline demographic and clinical features of study population according to tranversal rectal diameter.
|
|
|
|
| |
|---|---|---|---|---|
| Age, yrs, mean ± sd | 9.5 ± 3.4 | 9.8 ± 3.4 | 9.1 ± 3.3 | |
| Boys | 35 (43.2) | 19 (46.3) | 16 (40) | 0.565 |
| Girls | 46 (56.8) | 22 (53.7) | 24 (60) | |
| Aperta | 63 (77.8) | 31 (75.6) | 32 (80) | 0.635 |
| Occulta | 18 (22.2) | 10 (24.4) | 8 (20) | |
| L5 or above | 58 (71.6) | 30 (73.2) | 28 (70) | 0.752 |
| S1 or bellow | 23 (28.4) | 11 (26.8) | 12 (30) | |
| Myelomeningocele | 45 (55.6) | 24 (58.5) | 21 (52.5) | 0.637 |
| Meningocele | 9 (11.1) | 5 (12.2) | 4 (10) | |
| Lipoma | 15 (18.5) | 8 (19.5) | 7 (17.5) | |
| Indefinite type | 12 (14.8) | 4 (9.8) | 8 (20) | |
| Associated hydrocephalus, | 45 (55.6) | 21 (51.2) | 24 (60) | 0.427 |
| VCUG done, | 32 (39.5) | 15 (36.6) | 17 (42.5) | – |
| Low-grade VUR | 6 (7.4) | 5 (12.2) | 1 (2.5) | 0.586 |
| High-grade VUR | 26 (32.1) | 10 (24.4) | 16 (40) | |
| Antibiotic prophylaxis | 18 (22.2) | 11 (26.8) | 7 (17.5) | |
| Continent vesicostomy done, | 42 (51.9) | 17 (41.5) | 25 (62.5) | 0.058 |
| Uretherovesicostomy | 26 (32.1) | 11 (26.8) | 15 (37.5) | 0.174 |
| Appendicovesicostomy | 14 (17.3) | 6 (14.6) | 8 (20) | |
| prepucial vesicostomy | 2 (2.5) | 0 (0) | 2 (5) | |
|
| ||||
| Oxybutynin + CIC | 39 (48.1) | 0 (0) | 39 (97.5) | < 0.001 |
| Oxybutynin + CIC+ Bowel management | 42 (51.9) | 41 (100) | 1 (2.5) | |
| Orthopedic surgical intervention on hip, knee and foot deformities, | 20 (24.7) | 10 (24.4) | 10 (25) | 0.949 |
| Bed-ridden patients, | 20 (24.7) | 8 (19.5) | 12 (30) | 0.274 |
VCUG, voiding cystourethrograms; VUR, vesicoureteral reflux.
I, II and III degree, endoscopically treated with Deflux paste.
IV and V degree, surgically treated with execution of ureteroneocystostomy.
From distal end of ureter after executed ureteroneocystostomy.
Administered during the observation period (one-third of therapy dose every evening before bed).
Bowel management quit at least 12 months before the study began.
NA, not applicable.
Figure 1The correlation between urodynamic parameters and transverse rectal diameter stratified by therapy regimen. (A) The correlation between transverse rectal diameter and maximum bladder capacity. (B) The correlation between transverse rectal diameter and maximal detrusor pressure. (C) The correlation between transverse rectal diameter and compliance. (D) The correlation between transverse rectal diameter and leak point pressure. (E) The correlation between transverse rectal diameter and PVR.
Figure 2The Receiver operating curve for transverse rectal diameter in distinguishing children with upper urinary tract deterioration.
Urodynamic findings of study population by transversal rectal diameter.
|
|
|
|
|
|---|---|---|---|
| Maximum bladder capacity (ml) | 247 (189–298) | 112.5 (83–134.5) | <0.001 |
| MBC % EBC (ml) | 330 (240–390) | 330 (225–360) | <0.001 |
| Maximal detrusor pressure (cmH20) | 36 (31–39) | 75 (69–83.5) | <0.001 |
| Compliance (ml/cmH20) | 6 (5.1–7.5) | 2.5 (2–3.1) | <0.001 |
| Leak point pressure (cmH20) | 32 (29–39) | 69 (65–70) | <0.001 |
| PVR (ml) | 78 (68–97) | 171.5 (149–187) | <0.001 |
| PVR% EBC (ml) | 22.4 (19.5–26.9) | 62.1 (53.9–86.7) | <0.001 |
Med (25–75 th percentile).